Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The ...

The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the ...

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...

Pharmaceutical company Eli Lilly (LLY) has been raking it in lately thanks to its two flagship products: Mounjaro and Zepbound. These two have ...

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...

And so, another month has passed that was brimming with interesting developments in the pharmaceutical world ... file would be vital,” she writes. Lilly’s patent losses in Canada After ...

As part of our series looking at how pharma companies have adapted to the pandemic, Shannon Rush, leader of Eli Lilly and Company's diabetes business unit in Northern Europe, tells pharmaphorum ...

BERLIN, February 17, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for the ...

DOC Pharma strengthens its offerings with the acquisition of the Geopharma nutraceuticals portfolio, and the closing of the previously announced acquisition of Muscoril® New brand identity ...

PROVIDENCE, R.I. (AP) Kino Lilly Jr. had 23 points in Brown's 82-72 victory against Pennsylvania on Saturday night. Lilly also contributed five assists for the Bears (12-10, 4-5 Ivy League).